Company intelligence / Profile preview

Apexlens

Ownership: Private
Development stage: Commercial

Overview

Apexlens manufactures and markets high-quality silicone hydrogel contact lenses for vision correction and cosmetic use. Their products are commercially available in multiple countries and have received regulatory approvals such as CE marking, MOHW licenses, HSA registration, and others. The company emphasizes rigorous safety testing and customization services for clients.

Therapeutic areas: Ophthalmology
Modalities: Device (Contact lens)Silicone hydrogel contact lens
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on Apexlens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apexlens.

Explore the full profile